Oncology Drugs Market Research Report, Growth & Forecast

Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney cancerSorafenib is a targeted therapy used in the treatment of various cancers, including liver, kidney, and thyroid c...

Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures.Afinitor, a targeted therapy used in the treatment of various cancers,...

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics i...

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patie...

Epirubicin Hydrochloride is the hydrochloride salt of the 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, ther...

It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Lenalidomide has also shown efficacy in the class of hematological disorders...

Procarbazine is a chemotherapy medication used for the treatment of Hodgkin's lymphoma and brain cancers. For Hodgkin's it is often used together with chlormethine, vincristine, and prednisone while f...

RITUXAN is a type of antibody therapy that can be used alone or with chemotherapy.Rituxan, a monoclonal antibody used for the treatment of various cancers and autoimmune disorders, continues to witnes...

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patie...

Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010.Gemtuzumab Ozogamicin is an antibody-drug conjug...

Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is the tenth most common cause of cancer for women.The...

Kidney Cancer Treatment Drugs are drugs used to cure kidney cancer.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical m...

Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical aborti...

Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis...

Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010.Gemtuzumab Ozogamicin is an antibody-drug conjugate used to t...

Nelarabine is a chemotherapy drug used in T-cell acute lymphoblastic leukemia.Nelarabine is a medication used to treat T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Its effect...

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani...

Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invent...

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half...

Yervoy is a cancer medicine used in adults and adolescents from 12 years of age with advanced melanoma (a type of skin cancer) and in adults with advanced renal cell carcinoma (a kidney cancer). The g...

Nilotinib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). Tasigna, a targeted therapy used in the treatment of certain types of leukemia, is witnessing increasing demand. F...

TASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia.Tasigna, a targeted therapy used in the treatment of certain types of leukemia, is witnessing increasing de...

Arranon is a chemotherapy drug used in T-cell acute lymphoblastic leukemia.Nelarabine is a medication used to treat T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Its effective...

Atriance is a chemotherapy drug used in T-cell acute lymphoblastic leukemia.Nelarabine is a medication used to treat T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Its effectiv...

Anlotinib is a new, orally administered tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor (FGFR), platelet-derived growth fa...

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strateg...

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strateg...

According to our (Global Info Research) latest study, the global Melphalan Hydrochloride API market size was valued at US$ 327 million in 2025 and is forecast to a readjusted size of US$ 485 million b...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Pemetrexed Disodium market size was valued at US$ 912 million in 2025 and is forecast to a readjusted size of US$...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Plerixafor market size was valued at US$ 1004 million in 2025 and is forecast to a readjusted size of US$ 1361 mil...

According to our (Global Info Research) latest study, the global Tumor Microwave Ablation Devices market size was valued at US$ 598 million in 2025 and is forecast to a readjusted size of US$ 899 mill...

According to our (Global Info Research) latest study, the global Cobalt 60 Therapy Machine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 wit...

According to our (Global Info Research) latest study, the global Nuclear Radiation Therapeutic Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million b...

According to our (Global Info Research) latest study, the global Prostate Cancer Treatment Equipment market size was valued at US$ 4837 million in 2025 and is forecast to a readjusted size of US$ 8996...

According to our (Global Info Research) latest study, the global Body Cavity Thermoperfusion Therapy Machine market size was valued at US$ 14.69 million in 2025 and is forecast to a readjusted size of...

According to our (Global Info Research) latest study, the global In Vitro High Frequency Hyperthermia Machine market size was valued at US$ 195 million in 2025 and is forecast to a readjusted size of...

According to our (Global Info Research) latest study, the global Radio Frequency Tumor Therapy Machine market size was valued at US$ 1082 million in 2025 and is forecast to a readjusted size of US$ 27...

According to our (Global Info Research) latest study, the global Focused Ultrasound Tumor Ablation Machine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ mil...

According to our (Global Info Research) latest study, the global Chemotherapy Cold Hat market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a...

The global AR PROTAC Drugs for Cancer market size is predicted to grow from US$ million in 2025 to US$ 783 million in 2032; it is expected to grow at a CAGR of 26.3% from 2026 to 2032. No AR PROTAC Dr...

The global AR Targeted PROTAC Drugs market size is predicted to grow from US$ million in 2025 to US$ 626 million in 2032; it is expected to grow at a CAGR of 22.1% from 2026 to 2032. No AR Targeted PR...

Neuroendocrine Tumor Treatment Marketis is growing with a CAGR of 8.00% during the forecast period 2026-2035. The Neuroendocrine Tumor Treatment Market emerges as a key focus in DataM Intelligence lat...

According to our (Global Info Research) latest study, the global Proton Beam Therapy Devices market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 w...

According to our (Global Info Research) latest study, the global Automatic Ion Beam Therapy Apparatus market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million...

The global BNCT (Boron Neutron Capture Therapy) Injectable Drug market size is predicted to grow from US$ 62.61 million in 2025 to US$ 138 million in 2032; it is expected to grow at a CAGR of 11.8% fr...

Oncology Therapy Marketis is growing with a CAGR of 9.60% during the forecast period 2026-2035. The Oncology Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...

Global Head and Neck Cancer Therapeutics Market valued USD 2.33 billion in 2025 is anticipated to reach USD 8.01 billion by 2036, growing at 11.88% CAGR during forecast period. The Global Head and Nec...

The Metastatic Breast Cancer Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...

Pancreatic Cancer Treatment Market reached US$ 5.47 billion in 2025 and is expected to reach US$ 10.37 billion by 2033, growing with a CAGR of 7.40% during the forecast period 2026-2033. The Pancreati...

Uveal Melanoma Treatment Market reached US$ 1.54 billion in 2025 and is expected to reach US$ 2.7 billion by 2033, growing with a CAGR of 7.50% during the forecast period 2026-2033. The Uveal Melanoma...